Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 212 results found. Search for [ SARS-CoV-2 ]

Results 1 to 21 of 212
Joe C Mathew
November 24, 2020
In an open letter to Prime Minister Narendra Modi on November 24, the civil society representatives said the current incidence, prevalence, and fatality status of COVID-19 disease in India, do not call for such an approach


BusinessToday.In
November 23, 2020
Vaccine can be easily manufactured, transported and stored at domestic fridge temperature (2-8 degrees C). This means it can be easily distributed using existing medical facilities such as doctor's surgeries and local pharmacies, allowing for the vaccine to be deployed very rapidly, said Oxford University


BusinessToday.In
November 22, 2020
Bharat Biotech has started the phase- 3 trial of its potential COVID-19 vaccine, involving 26,000 volunteers this month across 25 centres in the country, including Hyderabad, Goa, Nagpur, Bhubaneswar, and Aligarh


Reuters
November 22, 2020
The agency said the antibodies are not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19


BusinessToday.In
November 21, 2020
Recently, a team of scientists at Cardiff University in the UK also made a similar claim that mouthwash could help destroy coronavirus within 30 seconds of being exposed to it in a lab


BusinessToday.In
November 21, 2020
Dr Thirumala-Devi Kanneganti, an Indian-born researcher currently working at St. Jude Children's Research Hospital in Tennessee, USA, has identified the drugs that could be used to prevent serious damage to COVID-19 patients


BusinessToday.In
November 21, 2020
Pfizer that its EUA submission is supported by solicited safety data from a randomised subset of approximately 8,000 participants aged 18 years or above and unsolicited safety data from approximately 38,000 trial participants


BusinessToday.In
November 19, 2020
Late-stage trials of the Oxford vaccine are still awaited but hopes are high that it'll also join frontrunners' league with Pfizer, Moderna and Russia's Sputnik V


BusinessToday.In
November 19, 2020
Convalescent Plasma Therapy (CPT) or passive immunotherapy has been tried in the past for treatment of viral infections like H1N1, Ebola and SARS-CoV-1 etc


Mansi Jaswal
November 18, 2020
Scientists said that mouthwash that contains at least 0.07 per cent of cetypyridinium chloride (CPC) showed 'promising signs' of being able to kill coronavirus when exposed in a lab


BusinessToday.In
November 16, 2020
The scientists found that the mutated virus not only replicates about 10 times faster but it was also much more infectious


PTI
November 14, 2020
According to the researchers, children have lower levels of a receptor protein that the coronavirus SARS-CoV-2 needs to invade airway epithelial cells in the lungs


PTI
November 10, 2020
They reported the design of a 'heat-tolerant' COVID-19 vaccine candidate and a rapid method to identify specific regions on the HIV envelopeprotein that are targeted by antibodies, which can help design effective vaccines


PTI
November 10, 2020
The coronavirus death toll climbed to 1,27,059 with 448 new fatalities, the data updated at 8 am showed


PTI
November 10, 2020
Pfizer said that the vaccine candidate was found to be more than 90 per cent effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis


Chitranjan Kumar
November 9, 2020
Coronavirus vaccine update: Based on current projections, Pfizer Inc and BioNTech expect to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses in 2021


BusinessToday.In
November 9, 2020
Researchers made their discovery while developing highly sensitive antibody tests for COVID-19. They compared the blood of COVID-19 patients with that of patients who had not had the disease


PTI
November 7, 2020
Scientists have found that some antibodies, created by the immune system during infection with common cold coronaviruses, can also target the COVID-19


BusinessToday.In
November 5, 2020
Coronavirus impact: The researchers found that there were increasing signs that coronavirus also impacts the nervous system, produces neurocognitive alterations as well as psychotic episodes


BusinessToday.In
November 4, 2020
COVID-19 vaccine update: Based on the success of the trials and regulatory approvals, we can expect vaccine to be available in India by January 2021, only if its proven immunogenic and efficacious, says SII CEO Adar Poonawalla


PAGES 1 OF 11  12345